Industry leading testing turnaround times to accelerate patient recovery.
Ability to identify pathogenic genotype with the highest sensitivity and specificity.
Identification of resistance genes can rapidly improve treatment and outcomes paradigms.
Easily identify complicated infections with multiple pathogenic and non-pathogenic micro-organisms.
Rapid test results and highly precise diagnosis allows accurate targeting of ID with proper antibiotic or antimicrobial.
Receive ID diagnosis and treatment plan including region specific data to help guide clinical decisions.
Reduce or perhaps eliminate trial and error diagnosis and medication or loss of valuable time in patient care.
More easily identify complex multi pathogenic and mixed biofilm samples.
Identification of resistance genes rapidly changes treatment and outcome paradigm.
U.S. RISK OF ANTIMICROBIAL RESISTANCE
U.S. Yearly Infectious Disease Deaths (CDC)
Antimicrobial-Resistant Infections (CDC)
Unnecessary Antibiotics Prescribed (CDC)
U.S. COST OF ANTIMICROBIAL RESISTANCE
Billion $ Healthcare Spend (CDC)
Billion $ Lost Productivity (CDC)
Additional Days – Prolonged & Costlier Care (CDC)
Million Additional Hospital Days Spent (CDC)